These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1438512)

  • 1. Bioavailability of two formulations of acetylsalicylic acid gums.
    Bousquet E; Tirendi S; Bonina FP; Montenegro L; Bianchi A; Ciampini N
    Pharmazie; 1992 Aug; 47(8):607-9. PubMed ID: 1438512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative bioavailability of aspirin from buffered, enteric-coated and plain preparations.
    Latini R; Cerletti C; de Gaetano G; Dejana E; Galletti F; Urso R; Marzot M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):313-8. PubMed ID: 3733281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic study of a new oral buffered acetylsalicylic acid (ASA) formulation in comparison with plain ASA in healthy volunteers.
    Viganò G; Garagiola U; Gaspari F
    Int J Clin Pharmacol Res; 1991; 11(3):129-35. PubMed ID: 1809699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The absorption of acetylsalicylic acid from an enteric-coated formulation and the inhibition of thromboxane formation.
    Anttila M; Kahela P; Uotila P
    Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):88-92. PubMed ID: 3410591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of acetylsalicylic acid for the prophylaxis of cardiovascular pathology].
    Castel JM; Artaza MA; Laporte JR
    Med Clin (Barc); 1991 May; 96(18):689-91. PubMed ID: 2072775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The bioavailability of combination preparations of acetylsalicylic acid and codeine phosphate].
    Spahn H; Altmayer P; Cattarius-Korb S; Krüger B; Lang E; Mutschler E; Sörgel F
    Arzneimittelforschung; 1985; 35(6):973-6. PubMed ID: 4026924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of administration route on pharmacokinetics of aspirin in the rabbit.
    Kergueris MF; Bourin M; Larousse C; Lasserre MP; Ortega A
    Methods Find Exp Clin Pharmacol; 1988 Mar; 10(3):171-5. PubMed ID: 3386327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ingestion of chilli pepper (Capsicum annuum) reduces salicylate bioavailability after oral asprin administration in the rat.
    Cruz L; Castañeda-Hernández G; Navarrete A
    Can J Physiol Pharmacol; 1999 Jun; 77(6):441-6. PubMed ID: 10537230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin kinetics and inhibition of platelet thromboxane generation-relevance for a solution of the "aspirin dilemma".
    Cerletti C; Latini R; Del Maschio A; Galletti F; Dejana E; de Gaetano G
    Thromb Haemost; 1985 Jun; 53(3):415-8. PubMed ID: 4049312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A highly sensitive HPLC method for the simultaneous determination of acetylsalicylic, salicylic and salicyluric acids in biologic fluids: pharmacokinetic, metabolic and monitoring implications.
    Krivosíková Z; Spustová V; Dzúrik R
    Methods Find Exp Clin Pharmacol; 1996 Oct; 18(8):527-32. PubMed ID: 9044241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Absolute bioavailability of a special sustained-release acetylsalicylic acid formulation].
    Lücker PW; Swoboda M; Wetzelsberger N
    Arzneimittelforschung; 1989 Mar; 39(3):391-4. PubMed ID: 2757664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of influence of glycine on the single dose pharmacokinetics of acetylsalicylic acid in man.
    Schurer M; Bias-Imhoff U; Schulz HU; Schwantes U; Riechers AM
    Int J Clin Pharmacol Ther; 1996 Jul; 34(7):282-7. PubMed ID: 8832303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on relative bioavailability of aspirin in afenca tablet].
    Yang J; Jiang X; He L; Zhou J; Li S; Lin S
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Dec; 20(4):661-3. PubMed ID: 14716871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of acetylsalicylic acid and its metabolites at low doses: a compartmental modeling.
    Dubovská D; Piotrovskij VK; Gajdos M; Krivosíková Z; Spustová V; Trnovec T
    Methods Find Exp Clin Pharmacol; 1995; 17(1):67-77. PubMed ID: 7623523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental study of the pharmacokinetics of acetylsalicylic acid upon transdermal administration].
    Polukhina OS; Basok IuB; Salomatina LA; Sevast'ianov VI
    Eksp Klin Farmakol; 2009; 72(3):29-32. PubMed ID: 19642589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lowering of plasma isoxicam concentrations with acetylsalicylic acid.
    Grace EM; Mewa AA; Sweeney GD; Rosenfeld JM; Darke AC; Buchanan WW
    J Rheumatol; 1986 Dec; 13(6):1119-21. PubMed ID: 3560102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ascolong: a new buccal dosage form of acetylsalicylic acid to be used and antiaggregant].
    Kokurina EV; Suslina ZA; Khromov GL; Davydo AB; Metelitsa VI; Ionova VG; Tanashian MM; Demina EG; Bochkareva EV; Belolipetskaia VG; Deev AD; Kucheriaeva NG; Zidra SI; Gorin NN; Rumiantsev DO
    Ter Arkh; 1998; 70(1):32-7. PubMed ID: 9532649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Which of the various acetylsalicylic acid preparations is the most appropriate in each indication? A pharmacokinetic study].
    Artaza MA; Castel JM; Cusidó E; Vidal X; Laporte JR
    Med Clin (Barc); 1988 Feb; 90(7):283-7. PubMed ID: 3361971
    [No Abstract]   [Full Text] [Related]  

  • 19. Bioavailability of acetylsalicylic acid and salicylic acid from rapid-and slow-release formulations, and in combination with dipyridamol.
    Brantmark B; Wåhlin-Boll E; Melander A
    Eur J Clin Pharmacol; 1982; 22(4):309-14. PubMed ID: 7106166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bioavailability of acetylsalicylic acid administered orally or rectally in the rabbit].
    Fehri B; Aiache JM; Boukef K
    J Pharm Belg; 1989; 44(1):5-10. PubMed ID: 2724047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.